Scotiabank Sticks to Their Buy Rating for EyePoint Pharmaceuticals (EYPT)
In a report released today, Greg Harrison from Scotiabank maintained a Buy rating on EyePoint Pharmaceuticals (EYPT – Research Report), with a ...
Le Lézard2d
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Keros Therapeutics, Inc. - KROS
Pomerantz LLP is investigating claims on behalf of investors of Keros Therapeutics, Inc. ("Keros" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or ...
6,242 Shares in Keros Therapeutics, Inc. (NASDAQ:KROS) Bought by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC acquired a new stake in Keros Therapeutics, Inc. (NASDAQ:KROS – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and ...
Keros Therapeutics, Inc. Being Investigated on Behalf of Keros Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details
NEW YORK, NY / ACCESS Newswire / January 31, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Keros ...